Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 5NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 34Lung Neoplasms 29Ovarian Neoplasms 23Carcinoma, Ovarian Epithelial 18Fallopian Tube Neoplasms 15Adenocarcinoma of Lung 14Neuroblastoma 13Central Nervous System Neoplasms 11Squamous Cell Carcinoma of Head and Neck 8Head and Neck Neoplasms 8Brain Neoplasms 8Brenner Tumor 7Adenocarcinoma, Bronchiolo-Alveolar 7Urinary Bladder Neoplasms 6Urethral Neoplasms 5Breast Neoplasms 5Astrocytoma 5Wilms Tumor 4Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Medulloblastoma 4Teratoma 3Radiation Injuries 3Optic Nerve Glioma 3Lymphoma 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Embryonal 3Carcinoma 3Thymoma 2

Interventions

Watchful Waiting 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Magnetic Resonance Spectroscopy 1Etoposide 1Cisplatin 1Carboplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms, Germ Cell and Embryonal × Carboplatin × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡